查詢結果分析
來源資料
頁籤選單縮合
題名 | 研發資源與研發組合關係之研究--國內製藥業之實證=The Study of R&D Resources and R&D Portfolio: An Empirical Study for Taiwan Pharmaceutical Industry |
---|---|
作者 | 賴士葆; 陳松柏; Lai, Shyh-bao; Chen, Sung-puo; |
期刊 | 管理評論 |
出版日期 | 19980100 |
卷期 | 17:1 1998.01[民87.01] |
頁次 | 頁1-20 |
分類號 | 418.41 |
語文 | chi |
關鍵詞 | 可用研發資源; 投入研發資源; 研發組合; 製藥業; Available R&D resource; Inputed R&D resource; R&D portfolio; Pharmaceutical; |
中文摘要 | 本研究探討公司「可用研發資源」及「研發組合」二構念之間關係,並對製藥單 一產業做實証分析。首先深入探討研發資源與策略形成的先後概念,將研發資源區分為「事 前的可用研發資源」,與「事後的投入研發資源」;對可用研發資源多寡性之定義衡量,採 取資源基礎理論中,將資源分為「資產類」與「能力類」,分別予以操作化。對於研發組合 則採用「市場策略目的」與「技術開發方式」兩種構面予以分析之。以臺灣製藥業廠商的實 証研究結果發現:當公司的可用研發資源愈豐富時,其研發產品的組合型態傾向於「產品數 較多、較攻取性的市場策略目的、較高整合程度之技術開發方式」之組合型態;反之,當公 司的可用研發資源愈貧瘠時,其研發產品的組合型態傾向於「產品數較少、較防守性的市場 策略目的、較低整合程度之技術開發方式」之組合型態。最後並對樣本廠商提供研發組合方 式型態之規範性建議。 |
英文摘要 | This research focused on studying the relationship between two concepts in a company: "available R&D resources" and "R&D portfolio", and to do an empirical study for Taiwan pharmaceutical industry. First, a deep explicatiion about the sequential concepts of R&D resources and how it forms a strategy are described. Second, "Ex Ante available" and "Ex Post inputted" are found as two categories of R&D resources. Third, the definition and the concepts about "asset resource" and "capability resource" is discussed based on "resources-based theory". Fourth, marketing strategy and technical development approach are two dimensions in analyzing the R&D portfolio. Finally, an empirical study of Taiwan pharmaceutical companies found:the richer R&D resources in a company, the R&D portfolio pattern tends to be more items, taking more aggressive marketing strategy and higher integrity in technical development approach. On the contrary, the poorer R&D resources in a company, the R&D portfolio pattern tends to be less items, taking more conservative marketing strategy and lower integrity in technical development approach. The result could provide a normative suggestion to pharmaceutical companies in Taiwan. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。